The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Oligonucleotides as Research, Diagnostic, and Therapeutic Agents
Open accessAbstract
Rapid drug discovery is a pressing need in the pharmaceutical industry. As new target proteins are proposed for therapeutic intervention, the methods of random screening or rational drug design may not be adequate to the challenge. SELEX1(1) -derived oligonucleotides, possessing shapes that interact with target molecules, may provide a surprising alternative to other ligand discovery technologies. In addition, the technology leads to a novel research idea that may enrich our understanding of the mechanisms by which cells and organisms integrate their metabolic activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
Self-citationIn vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
The Energy Landscapes and Motions of Proteins
Frauenfelder, H., Sligar, S. G., & Wolynes, P. G. (1991) · Science · doi:10.1126/science.1749933 · Cited by 3,250
Jacob, F. (1977) · Science · doi:10.1126/science.860134 · Cited by 2,690
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Breaker, R. R., & Joyce, G. F. (1994) · Chemistry & Biology · doi:10.1016/1074-5521(94)90014-0 · Cited by 1,476
Regulating the fate of mRNA: the control of cellular iron metabolism
Klausner, R. D., Rouault, T. A., & Harford, J. B. (1993) · Cell · doi:10.1016/0092-8674(93)90046-s · Cited by 1,210
High-Resolution Molecular Discrimination by RNA
Jenison, R. D., Gill, S. C., Pardi, A., & Polisky, B. (1994) · Science · doi:10.1126/science.7510417 · Cited by 1,188
Gallop, M. A., Barrett, R. W., Dower, W. J., Fodor, S. P. A., & Gordon, E. M. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00035a001 · Cited by 1,135
Isolation of high affinity human antibodies directly from large synthetic repertoires.
Griffiths, A. D., Williams, S. C., Hartley, O., Tomlinson, I. M., Waterhouse, P., Crosby, W. L., Kontermann, R. E., Jones, P. T., Low, N. M., & Allison, T. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06626.x · Cited by 962
Cited by
Aptamers as targeted therapeutics: current potential and challenges
Zhou, J., & Rossi, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.199 · Cited by 2,221
Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics
Jayasena, S. D. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.9.1628 · Cited by 2,144
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754
“There were many examples of high affinity RNA and DNA aptamers selected against human proteins [19].”
BackgroundSelf-citationIn Vitro Selection of Functional Nucleic Acids
Wilson, D. S., & Szostak, J. W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.611 · Cited by 1,206
Oligonucleotide inhibitors of human thrombin that bind distinct epitopes
Tasset, D. M., Kubik, M. F., & Steiner, W. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1275 · Cited by 837
Rohloff, J. C., Gelinas, A. D., Jarvis, T. C., Ochsner, U. A., Schneider, D. J., Gold, L., & Janjic, N. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.49 · Cited by 533
Self-citationNucleic Acid Selection and the Challenge of Combinatorial Chemistry
Osborne, S. E., & Ellington, A. D. (1997) · Chemical Reviews · doi:10.1021/cr960009c · Cited by 520
A review of molecular recognition technologies for detection of biological threat agents
Iqbal, S. S., Mayo, M. W., Bruno, J. G., Bronk, B. V., Batt, C. A., & Chambers, J. P. (2000) · Biosensors and Bioelectronics · doi:10.1016/s0956-5663(00)00108-1 · Cited by 507
Aptamers as therapeutic and diagnostic agents
Brody, E. N., & Gold, L. (2000) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(99)00004-5 · Cited by 494
Self-citationTargeted nanoparticles for cancer therapy
Gu, F. X., Karnik, R., Wang, A. Z., Alexis, F., Levy-Nissenbaum, E., Hong, S., Langer, R. S., & Farokhzad, O. C. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70083-x · Cited by 478
Mirror-image RNA that binds D-adenosine
Klußmann, S., Nolte, A., Bald, R., Erdmann, V. A., & Fürste, J. P. (1996) · Nature Biotechnology · doi:10.1038/nbt0996-1112 · Cited by 399
Gopinath, S. C. B. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-006-0826-2 · Cited by 392
Inhibitory DNA Ligands to Platelet-Derived Growth Factor B-Chain
Green, L. S., Jellinek, D., Jenison, R., Östman, A., Heldin, C.-H., & Janjic, N. (1996) · Biochemistry · doi:10.1021/bi961544+ · Cited by 390
Rational design of allosteric ribozymes
Tang, J., & Breaker, R. R. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90197-6 · Cited by 383
Specificity, free energy and information content in protein–DNA interactions
Stormo, G. D., & Fields, D. S. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01187-6 · Cited by 354
Noiri, E., Peresleni, T., Miller, F., & Goligorsky, M. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118681 · Cited by 343
Inhibition of human telomerase activity by peptide nucleic acids
Norton, J. C., Piatyszek, M. A., Wright, W. E., Shay, J. W., & Corey, D. R. (1996) · Nature Biotechnology · doi:10.1038/nbt0596-615 · Cited by 343
Breaker, R. R. (1997) · Nature Biotechnology · doi:10.1038/nbt0597-427 · Cited by 343
Encoded self-assembling chemical libraries
Melkko, S., Scheuermann, J., Dumelin, C. E., & Neri, D. (2004) · Nature Biotechnology · doi:10.1038/nbt961 · Cited by 341
An enzyme-linked oligonucleotide assay
Drolet, D. W., Moon-McDermott, L., & Romig, T. S. (1996) · Nature Biotechnology · doi:10.1038/nbt0896-1021 · Cited by 335
THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASE
ADAMIS, A. P., & SHIMA, D. T. (2005) · Retina · doi:10.1097/00006982-200502000-00001 · Cited by 334
Kraemer, S., Vaught, J. D., Bock, C., Gold, L., Katilius, E., Keeney, T. R., Kim, N., Saccomano, N. A., Wilcox, S. K., Zichi, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026332 · Cited by 310
Self-citationMultivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
McNamara, J. O., Kolonias, D., Pastor, F., Mittler, R. S., Chen, L., Giangrande, P. H., Sullenger, B., & Gilboa, E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33365 · Cited by 310
Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
Pastor, F., Kolonias, D., Giangrande, P. H., & Gilboa, E. (2010) · Nature · doi:10.1038/nature08999 · Cited by 294
Forssen, E., & Willis, M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00083-5 · Cited by 287
Interlocking structural motifs mediate molecular discrimination by a theophylline-binding RNA
Zimmermann, G. R., Jenison, R. D., Wick, C. L., Simorre, J.-P., & Pardi, A. (1997) · Nature Structural Biology · doi:10.1038/nsb0897-644 · Cited by 285
Green, L. S., Jellinek, D., Bell, C., Beebe, L. A., Feistner, B. D., Gill, S. C., Jucker, F. M., & Janjić, N. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90032-2 · Cited by 284
Selection of RNA amide synthases
Wiegand, T. W., Janssen, R. C., & Eaton, B. E. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90223-4 · Cited by 153
Life's Simple Measures: Unlocking the Proteome
Brody, E., Gold, L., Mehan, M., Ostroff, R., Rohloff, J., Walker, J., & Zichi, D. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.06.021 · Cited by 54
Self-citation
Metadata
- Authors
- Gold, L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-06
- Volume
- 270
- Issue
- 23
- Pages
- 13581-13584
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2043266732
- Cited by
- 266
- References
- 35
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.